Investment incentives
A nationally competitive package for pharmaceutical and medical device manufacturers, administered through TISEZA and coordinated by PIAT.
| Instrument | Benefit |
|---|---|
| Corporate income tax | 20% for the first 5 years (standard rate is 30%) |
| Import duty - capital goods & raw materials | Zero import duty on capital goods and raw materials |
| Import duty - deemed capital goods | 75% exemption on deemed capital goods |
| VAT relief | VAT relief on essential medicines and inputs |
| TMDA registration fees | Reduced from USD 2,000 to USD 400 (80% reduction) |
| MSD procurement preference | 15% price preference and multi-year framework contracts |
| Land allocation | Free land allocation, on agreed terms |
| Profit repatriation | Free repatriation of profits in convertible currency |
| Immigration | 10 expatriate quota, scaling with project size |
Investor tiers
| Tier | Threshold | Site |
|---|---|---|
| Normal | ≥ USD 500K | Mloganzila |
| Strategic | ≥ USD 50M | Mloganzila / Bagamoyo |
| Special Strategic | ≥ USD 300M | Mloganzila / Bagamoyo |
“Once you invest, comply with WHO-PQ and GMP, and manufacture competitively in Tanzania, the Government will actively protect your market position.”
MSD framework procurement is subject to formal agreement upon investment commencement.
Indicative savings calculator
Estimate first-year savings from the core incentive instruments.
Indicative estimates only, based on standard rates; your confirmed package is agreed with PIAT during joint structuring.